BLACK DIAMOND THERAPEUTICS I (BDTX) Stock Earnings & Estimates
USA - NASDAQ:BDTX - US09203E1055 - Common Stock
4.0268 USD
+0.14 (+3.52%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -100.00% | N/A | N/A 209.18% | N/A 371.89% | N/A 175.96% | N/A 42.48% | N/A 45.45% | |||||||||
| EBITDA YoY % growth | -4.1M | -8.86M -116.10% | -29.28M -230.47% | -69.52M -137.43% | -126.66M -82.19% | -92.32M 27.11% | -86.023M 6.82% | -78.438M 8.82% | N/A 118.48% | N/A -502.12% | N/A -23.50% | N/A -15.02% | N/A -7.60% | N/A 58.97% | N/A 245.95% | N/A 158.37% | |
| EBIT YoY % growth | -4.12M | -8.9M -116.02% | -29.33M -229.55% | -69.57M -137.20% | -126.87M -82.36% | -92.83M 26.83% | -86.46M 6.86% | -78.781M 8.88% | N/A 116.92% | N/A -625.00% | N/A -48.41% | N/A -17.87% | N/A 22.79% | N/A 118.24% | N/A 496.89% | N/A 95.29% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.05 69.63% | -3.47 -69.22% | -2.52 27.36% | -1.88 25.40% | -1.27 32.45% | N/A 128.61% | N/A -336.26% | N/A -20.24% | N/A 26.63% | N/A 59.26% | N/A 352.07% | N/A 34.65% | N/A 60.71% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 14.27% | -0.19 33.58% | -0.20 -120.30% | -0.21 -8.71% | -0.20 17.85% | -0.20 -9.69% | -0.17 12.82% | -0.18 11.11% | -0.19 1.72% | -0.21 -5.00% |
| Revenue Q2Q % growth | -100.00% | |||||||||
| EBITDA Q2Q % growth | -13.719M 23.24% | -13.852M 22.75% | -14.158M -125.92% | -14.423M -8.88% | -16.993M -23.87% | -17.473M -26.14% | -18.727M -32.28% | -20.043M -38.97% | -21.471M -26.35% | -23.042M -31.87% |
| EBIT Q2Q % growth | -14.26M 21.35% | -14.357M 21.44% | -14.527M -126.64% | -14.845M -10.62% | -16.346M -14.63% | -44.852M -212.40% | -18.788M -29.33% | -20.094M -35.36% | -21.522M -31.67% | -23.093M 48.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.19 47.22% | -0.25 | 0.06 | 24.48% |
| Q1 2025 Q2Q % growth | 0.98 380.00% | 0.02 | 0.96 | 4,421.34% |
| Q4 2024 Q2Q % growth | -0.28 17.65% | -0.32 | 0.04 | 12.77% |
| Q3 2024 Q2Q % growth | -0.28 37.78% | -0.38 | 0.10 | 26.57% |
| Q2 2024 Q2Q % growth | -0.36 30.77% | -0.39 | 0.03 | 8.83% |
| Q1 2024 Q2Q % growth | -0.35 38.60% | -0.44 | 0.09 | 21.12% |
| Q4 2023 Q2Q % growth | -0.34 42.37% | -0.48 | 0.14 | 28.47% |
| Q3 2023 Q2Q % growth | -0.45 25.00% | -0.50 | 0.05 | 9.32% |
| Q2 2023 Q2Q % growth | -0.52 17.46% | -0.55 | 0.03 | 4.86% |
| Q1 2023 Q2Q % growth | -0.57 18.57% | -0.62 | 0.05 | 8.01% |
| Q4 2022 Q2Q % growth | -0.59 16.90% | -0.64 | 0.05 | 7.84% |
| Q3 2022 Q2Q % growth | -0.60 38.14% | -0.65 | 0.05 | 8.09% |
| Q2 2022 Q2Q % growth | -0.63 33.68% | -0.69 | 0.06 | 9.20% |
| Q1 2022 Q2Q % growth | -0.70 16.57% | -0.77 | 0.07 | 8.66% |
| Q4 2021 Q2Q % growth | -0.71 -12.70% | -1.03 | 0.32 | 31.31% |
| Q3 2021 Q2Q % growth | -0.97 -94.00% | -1.00 | 0.03 | 2.80% |
| Q2 2021 Q2Q % growth | -0.95 -131.71% | -0.86 | -0.09 | -10.83% |
| Q1 2021 Q2Q % growth | -0.84 -64.51% | -0.69 | -0.15 | -21.29% |
| Q4 2020 Q2Q % growth | -0.63 86.39% | -0.64 | 0.01 | 1.96% |
| Q3 2020 Q2Q % growth | -0.50 | -0.53 | 0.03 | 6.45% |
| Q2 2020 Q2Q % growth | -0.41 | -0.45 | 0.04 | 9.47% |
| Q1 2020 Q2Q % growth | -0.51 | -0.49 | -0.02 | -3.31% |
| Q4 2019 Q2Q % growth | -4.63 | -1.40 | -3.23 | -231.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 70M | 17.85M | 52.15M | 292.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.94% | 3.29% | 14.3% | 863.34% |
| Revenue | N/A | N/A | 0% | 50% |